[91F12-91F12];[92B4-92B4];
A set of ~800 largely isogenic deficiency stocks created by FLP-induced recombination between FRT-carrying transgenic insertions; molecularly defined deletion endpoints correspond to initial location of the progenitor insertions. Designed to fill gaps in deletion coverage and breakpoint placement; also used to replace older available deficiencies that have not been molecularly mapped.
91F12;92B4
Breakpoint from FlyBase's release 5 sequence location of progenitor insertion.
Inferred to overlap with: Df(3R)BSC850.
Df(3R)BSC475 heterozygotes have a Delta wing phenotype (broadened distal end of longitudinal veins).
The presence of P+PBac{XP5.WH5}BSC475 was verified using the PCR methods and primers described in FBrf0175003.
The cytological breakpoints of Df(3R)BSC475 predicted from the Release 5 genomic coordinates of the PBac{WH}CG5237f01664 and P{XP}d07656 transposable element insertions sites are 91F12;92B4.